Bremelanotide Side Effects: 7 Things to Watch For (and How to Manage Them)

Bremelanotide at a glance:

• Drug class: Melanocortin receptor agonist
• Manufacturer: Palatin Technologies / AMAG Pharmaceuticals
• FDA approved: 2019
• Route: subcutaneous injection autoinjector
• Typical frequency: as needed before sexual activity
• Half-life: approximately 2.7 hours
• Cash price (US): $300-$1,000/month

Most Bremelanotide side effects are predictable, manageable, and time-limited. The minority that aren't deserve real attention. We separate the two below.

Common Side Effects of Bremelanotide

The side effects most often reported with Bremelanotide:

• Nausea — most common in the first 4-8 weeks of titration; usually improves with smaller meals and slower eating.
• Flushing — transient warming of the skin; typically resolves within minutes.
• Headache — typically mild and self-limited; persists in only a small minority of users.
• Injection-site reactions — usually minor redness or itching; rotating injection sites helps.

These tend to be dose-related. They are most prominent during dose escalation and typically improve once the body adapts to a steady dose.

Serious Risks

Less common but important:

• Transient blood pressure elevation — see the prescribing information for full risk language for details. Notify your clinician promptly if relevant symptoms develop.
• Hyperpigmentation — see the prescribing information for full risk language for details. Notify your clinician promptly if relevant symptoms develop.

How to Manage Common Side Effects

Track what you feel. Side effects are easier to discuss when you have a record of when they appear and how severe they are.

Don't change the dose on your own. Many side effects improve with time at a steady dose; stopping and restarting often resets the adaptation period.

Stay hydrated and eat regularly. Generic advice that nonetheless prevents many otherwise-avoidable side-effect calls.

Communicate with your clinician. Most side effects have a management strategy; the worst outcomes happen when people stop the drug silently and don't get the next-step plan.

For dose-titration questions, see our Bremelanotide dosage guide.

Side Effects vs. Withdrawal Effects

It's worth distinguishing between side effects (from taking the drug) and withdrawal or rebound effects (from stopping it). For Bremelanotide, the most relevant rebound concern is compound-specific — see the prescribing information.

When to Stop and Call Someone

These symptoms warrant prompt clinical evaluation:

• Severe abdominal pain (especially radiating to the back) — possible pancreatitis
• Vision changes
• Signs of allergic reaction (hives, throat tightness, difficulty breathing)
• Severe vomiting or dehydration
• Persistent symptoms that worsen rather than improve

Side Effects in Context

Most people who take Bremelanotide experience some side effects. Most of those are tolerable and improve with time. The decision to continue is a balance between benefit and tolerance, made together with a clinician.

For people weighing whether Bremelanotide is the right fit, our Bremelanotide results page covers the upside.

Bottom Line

If you're considering stopping Bremelanotide for side effects, talk to your clinician first. The fix is often a small adjustment, not a discontinuation.

Frequently Asked Questions

Related Reading

• What Is Bremelanotide? Everything You Should Know Before Starting
• Bremelanotide Results: What the Real Numbers Show in 2026
• Why Bremelanotide Costs So Much (and 5 Ways to Pay Less)
• Bremelanotide Cycle and Protocol: What Researchers Actually Use
• hCG: The Complete 2026 Guide (Mechanism, Dosing, Cost)
• What Is Oxytocin? Everything You Should Know Before Starting

Sources

• Kingsberg SA et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder. Obstet Gynecol 2019;134:899.
• Skorupskaite K et al. Kisspeptin and Reproduction in Humans. Hum Reprod Update 2014;20:485.

This page is informational only and is not medical advice. Stop Bremelanotide and seek medical attention if you experience severe symptoms.